Robert R. Schmidt

Robert R. Schmidt is a Managing Director on the U.S. Buyout team focused on private equity investments in the healthcare sector. He is based in New York.

Since joining Carlyle in 2011, Mr. Schmidt has been involved in a number of the firm’s investments globally, including Beats Electronics, Included Health (fka Grand Rounds), Medline, MedRisk, One Medical, QuidelOrtho (fka Ortho Clinical Diagnostics), Resonetics, Sedgwick and Unchained Labs. He is currently a member of the Board of Directors of Included Health, Medline, MedRisk, QuidelOrtho, Resonetics and Unchained Labs.

Prior to joining Carlyle, Mr. Schmidt worked at Welsh, Carson, Anderson & Stowe, a private equity firm focused on healthcare and technology investments, and Merrill Lynch Global Private Equity, focused on buyouts in North America.

Mr. Schmidt received his M.B.A. from Harvard Business School and a B.S. in economics from The Wharton School at the University of Pennsylvania, where he is currently a member of the External Advisory Board at the Leonard Davis Institute of Health Economics.